Showing results (11-20 of 80) with videos related to
Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|August 2, 2003
Functional expression of the multidrug resistance protein 1 in microgliaShannon Dallas, Xiaoping Zhu, Sylvain Baruchel, et al.Nursing Inquiry|February 15, 2008
Using puppetry to elicit children's talk for researchIris Epstein, Bonnie Stevens, Patricia McKeever, et al.Neoplasia (New York, N.Y.)|February 28, 2007
Tissue microenvironment modulates CXCR4 expression and tumor metastasis in neuroblastomaLibo Zhang, Herman Yeger, Bikul Das, et al.Pediatric Blood & Cancer|May 8, 2013
Treatment with topotecan plus cyclophosphamide in children with first relapse of neuroblastomaKaleem Ashraf, Furqan Shaikh, Paul Gibson, et al.Journal of Pediatric Hematology/Oncology|November 23, 2006
A pilot pharmacokinetic and antiangiogenic biomarker study of celecoxib and low-dose metronomic vinblastine or cyclophosphamide in pediatric recurrent solid tumorsDiana Stempak, Janet Gammon, Jacqueline Halton, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 2016
Combined Antitumor Therapy with Metronomic Topotecan and Hypoxia-Activated Prodrug, Evofosfamide, in Neuroblastoma and Rhabdomyosarcoma Preclinical ModelsLibo Zhang, Paula Marrano, Bing Wu, et al.Journal of Pediatric Hematology/Oncology|April 17, 2004
Factors influencing survival in children with recurrent neuroblastomaLoretta Lau, Derek Tai, Sheila Weitzman, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 2, 2014
The neuroblastoma and ganglion components of nodular ganglioneuroblastoma are genetically similar: evidence against separate clonal originsPaola Angelini, Sylvain Baruchel, Paula Marrano, et al.Stem Cells (Dayton, Ohio)|May 10, 2008
Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fractionBikul Das, Rika Tsuchida, David Malkin, et al.Nuclear Medicine Communications|December 4, 2004
Meta-[123I]iodobenzylguanidine is selectively radiotoxic to neuroblastoma cells at concentrations that spare cells of haematopoietic lineageYing He, Bikul Das, Sylvain Baruchel, et al.Pageof 8